{"name": "Aptalis Pharma",
 "permalink": "aptalis",
 "crunchbase_url": "http://www.crunchbase.com/company/aptalis",
 "homepage_url": "http://www.aptalispharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "Axcan Pharma",
 "email_address": "",
 "phone_number": "(450) 467-2600",
 "description": "Pharmaceutical Manufacturer",
 "created_at": "Sat Dec 04 06:04:26 UTC 2010",
 "updated_at": "Thu Aug 18 23:13:21 UTC 2011",
 "overview": "\u003Cp\u003EAptalis Pharma (known as Axcan Pharma until May 2011) is a privately-held, leading specialty pharmaceutical company that develops and markets a wide range of products to treat gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency. Aptalis hopes to improve the quality of care and health of patients suffering from gastrointestinal diseases and disorders by providing effective therapies for patients and their specialized caregivers.\u003C/p\u003E\n\n\u003Cp\u003EAptalis was acquired by \u003Ca href=\"/company/tpg-capital\" title=\"TPG Capital\" rel=\"nofollow\"\u003ETPG Capital\u003C/a\u003E in 2008, and it acquired \u003Ca href=\"/company/eurand\" title=\"Eurand\" rel=\"nofollow\"\u003EEurand\u003C/a\u003E in 2010. It \u003Ca href=\"http://www.thepressreleasewire.com/client/aptalispharma/release.jsp?actionFor=1437343\u0026amp;releaseSeq=0\u0026amp;year=2011\" title=\"changed its name\" rel=\"nofollow\"\u003Echanged its name\u003C/a\u003E from Axcan Pharma to Aptalis in May 2011.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       59],
      "assets/images/resized/0011/2830/112830v2-max-150x150.png"],
     [[250,
       99],
      "assets/images/resized/0011/2830/112830v2-max-250x250.png"],
     [[278,
       111],
      "assets/images/resized/0011/2830/112830v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Frank",
      "last_name": "Verwiel",
      "permalink": "frank-verwiel",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6452/266452v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6452/266452v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6452/266452v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Research Officer",
    "person":
     {"first_name": "Robert",
      "last_name": "Becker",
      "permalink": "robert-becker",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6859/266859v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6859/266859v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6859/266859v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Senior Vice President and CFO",
    "person":
     {"first_name": "Steve",
      "last_name": "Gannon",
      "permalink": "steve-gannon",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6861/266861v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6861/266861v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6861/266861v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Executive Vice President and COO",
    "person":
     {"first_name": "David",
      "last_name": "W. Mims",
      "permalink": "david-w-mims",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6825/266825v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6825/266825v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6825/266825v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President, International Specialty Pharmaceuticals",
    "person":
     {"first_name": "Jean",
      "last_name": "Louis Anspach",
      "permalink": "jean-louis-anspach",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6821/266821v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6821/266821v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6821/266821v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Medical Officer",
    "person":
     {"first_name": "Ruth",
      "last_name": "Thieroff-Ekerdt",
      "permalink": "ruth-thieroff-ekerdt",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6866/266866v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6866/266866v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6866/266866v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "President, ",
    "person":
     {"first_name": "John",
      "last_name": "Fraher",
      "permalink": "john-fraher",
      "image":
       {"available_sizes":
         [[[80,
            95],
           "assets/images/resized/0026/6823/266823v1-max-150x150.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6823/266823v1-max-250x250.jpg"],
          [[80,
            95],
           "assets/images/resized/0026/6823/266823v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 1300000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://cnrp.ccnmatthews.com/client/axcan/n/release.jsp?actionFor=825264\u0026releaseSeq=0\u0026year=2008",
   "source_description": "Axcan Announces Completion of Transaction With TPG Capital",
   "acquired_year": 2008,
   "acquired_month": 2,
   "acquired_day": 25,
   "acquiring_company":
    {"name": "TPG Capital",
     "permalink": "tpg-capital",
     "image":
      {"available_sizes":
        [[[150,
           63],
          "assets/images/resized/0015/0114/150114v1-max-150x150.png"],
         [[176,
           75],
          "assets/images/resized/0015/0114/150114v1-max-250x250.png"],
         [[176,
           75],
          "assets/images/resized/0015/0114/150114v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [{"price_amount": 583000000.0,
    "price_currency_code": "USD",
    "term_code": "cash",
    "source_url": "http://www.thepressreleasewire.com/client/axcan/n/release.jsp?actionFor=1361779\u0026releaseSeq=0\u0026year=2010",
    "source_description": "Eurand to be Acquired by Axcan for $12.00 per Share in Cash",
    "acquired_year": 2010,
    "acquired_month": 12,
    "acquired_day": 1,
    "company":
     {"name": "Eurand",
      "permalink": "eurand",
      "image":
       {"available_sizes":
         [[[150,
            59],
           "assets/images/resized/0011/2831/112831v2-max-150x150.png"],
          [[250,
            99],
           "assets/images/resized/0011/2831/112831v2-max-250x250.png"],
          [[278,
            111],
           "assets/images/resized/0011/2831/112831v2-max-450x450.png"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "597 Laurier Boulevard",
    "address2": "Mont-Saint-Hilaire",
    "zip_code": "J3H 6C4",
    "city": "Quebec",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null},
   {"description": "Bridgewater, NJ",
    "address1": "100 Somerset Corporate Boulevard",
    "address2": "",
    "zip_code": "08807",
    "city": "Bridgewater",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}